Renalytix Plc
RNLXY
$0.225
$0.00853.93%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -10.92% | 9.53% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -10.92% | 9.53% | |||
Cost of Revenue | -23.27% | -8.49% | |||
Gross Profit | 177.78% | 154.55% | |||
SG&A Expenses | -27.61% | 16.62% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -24.50% | -8.39% | |||
Operating Income | 25.94% | 9.96% | |||
Income Before Tax | 33.19% | 8.64% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 33.16% | 8.64% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 33.16% | 8.64% | |||
EBIT | 25.94% | 9.96% | |||
EBITDA | 26.14% | 10.02% | |||
EPS Basic | 12.70% | 35.44% | |||
Normalized Basic EPS | 4.80% | 35.73% | |||
EPS Diluted | 12.70% | 36.00% | |||
Normalized Diluted EPS | 4.80% | 35.73% | |||
Average Basic Shares Outstanding | -23.50% | 41.48% | |||
Average Diluted Shares Outstanding | -23.50% | 41.48% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |